BioSpace News Archive

Volpara Health Technologies Ltd. (ASX: VHT), a global leader in software for the early detection and prevention of cancer, was featured in two peer reviewed studies published during this year’s Radiological Society of North America (RSNA) annual meeting.

Edenbridge Pharmaceuticals, the U.S. subsidiary of Dexcel Pharma, announced that Douglas S. Boothe has been named Chief Executive Officer, effective January 1, 2024.

CellFE Inc., a life sciences tools company commercializing a microfluidics-based cellular engineering platform, today announced its CEO Alla Zamarayeva, PhD, will be presenting at two conferences in January.

QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”) has received 510(K) clearance from the U.S. Food and Drug Administration for its innovative Savanna PCR platform and Savanna HSV 1+2/VZV in vitro diagnostic test for the detection and differentiation of Herpes simplex virus type 1 (HSV-1).

Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the 2024 Goldman Sachs Healthcare C-Suite Unscripted Conference in New York City on Thursday, January 4, 2024.

Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, today announced that results from the initial cohort of patients in an ongoing 24-week Phase 2 clinical trial of batoclimab in patients with Graves’ disease meaningfully exceeded 50% response rates.

Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for people living with devastating inflammation-related diseases, today outlined its global registrational program for ANX007, a first-in-class C1q and classical complement inhibitor, for the treatment of patients with geographic atrophy (GA).

Mercury Bio, (www.mercurybio.com) a Santa Fe, NM–based biotech company commercializing an innovative and highly disruptive drug delivery platform, today announced that Chief Executive Officer Bruce McCormick and Chief Science Officer Richard Sayre, Ph.D., will be presenting at the 2024 Biotech Showcase investors and corporate development conference at 11:00 AM on Monday, January 8, 2024.

We are thrilled to announce that Charles Brown, the President and CEO of LifeLabs, has been honoured with the prestigious Leadership Excellence in Medical Diagnostics and Laboratory Testing in the 2023 CEO Healthcare Awards, presented by CEO Today magazine.

Voom™ Medical Devices, Inc. (“Voom”), a trailblazing orthopedic medical device company and pioneer in minimally invasive bunion surgery (MIBS) solutions, proudly announces the debut of www.Bunionplasty.com.